Archived News & Announcements

Archived News

September 15, 2014

OHSU startup Orexigen earns FDA approval
The office of Technology Transfer and Business Development is happy to announce that a drug from Orexigen Therapeutics Inc., called Contrave, has been approved by the FDA. This drug helps with weight management, along with a reduced-calorie diet and increased physical activity, in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) who also have at least one weight-related comorbid condition. To read more about Orexigen Therapeutics Inc., click HERE.

August 6, 2014
Inventor Spotlight: Michael P. Hutchens, MD, MA
Every quarter, TTBD will highlight a particularly innovative or note worthy OHSU inventor and invention at the university. For the summer 2014 quarter, our office would like to congratulate Michael P. Hutchens, M.D., M.A., for his work on the “Disinfection device for medical access sites” and the “Anesthetic vapor delivery device” that he has created and submitted to our office. To read more on Michael Hutchens and inventions developed at OHSU, please click HERE.

May 20, 2014
New health science venture fund formed with OHSU help
OHSU is paying Allegory Venture Partners up to $1.2 million over a two-year period to support the fund’s launch and operation. Allegory is attempting to raise at least $40 million over that time, with an eventual target of $100 million for seed and follow-on funding in emerging life science companies. Allegory will be able to examine new technologies from OHSU research programs. Read more here.

May 20, 2014
PDC opens 2014 startup PDX challenge, focused on women & minorities
Up to six startup businesses will receive a $15,000 working capital grant, a full year of rent-free office space in the New Market Theater building at 115 SW Ash in Portland’s Old Town Chinatown neighborhood, free professional advice and services, and free access to entrepreneurial organizations and programs. Read the Press Release here.

February 26, 2014
Discovery Fast Track Challenge creates opportunities for Academic Researchers
Help your institution win a partnership with GlaxoSmithKline (GSK) scientists by submitting your project to the Discover Fast Track Challenge. For successful applicants, this will help drive your research forward and could lead to a GSK partnership for the development of a new medicine. To learn more, view the Challenge Flyer.

January 8, 2014
Portland Startup hopes to change the face of medical training
ReelDX, an OHSU startup, believes it's leading to better, faster medical diagnoses in children and potentially saving lives. Read more HERE about ReelDX in their article on KATU News

December 5, 2013
News Release: OHSU, PSU, PDC partner on grants to startups
Six local startup companies will receive grants of up to $30,000 through a pilot program to promote technology commercialization sponsored by the Portland Development Commission in partnership with OHSU and PSU. To read the full press release, click HERE.

October 28, 2013
ReelDX advances medical education bringing video learning to health professionals
ReelDX, a recent OHSU startup company, launched a series of video cases covering over 250 topics to help educate current and future medical professionals. These videos offer a concentrated experience, helping professionals hone their diagnostic and patient care abilities. To read the full article, click HERE.

July 30, 2013
Inventive OHSU postdoc "traps" scientific creativity to solve problems
OHSU postdoc Lulu Cambronne invents RISC-trap, a new and powerful lab technique to empirically identify specific microRNA targets in cells. To read her full story, click HERE.

June 27, 2013
Wondering how to subscribe to the quarterly TTBD newsletter? Stay up to date and find out about all of the latest happenings in TTBD at OHSU. Highlights include information for faculty, research ranked staff, post-docs and students. To be added to the distribution list .

May 30, 2013 
The Food and Drug Administration granted 501(k) clearance to a muscle and joint rehabilitation medical device developed by OHSU Scientist Dr. Paul Cordo, Ph.D., and AMES Technology, Inc. To read the full news release click HERE. May 22, 2013 Medical device manufacturer Neuro Kinetics Inc. has licensed software from OHSU that helps researchers better understand abnormalities within vestibular systems. Read the full post HERE.

May 15, 2013 
Breast and prostate cancer tests are just the beginning of the Cepheid collaboration with OHSU. Read the full article HERE.

May 10, 2013 
Read about the fifth annual Willamette Angel Conference results in the Portland Business Journal. This year's investors doubled the amount of investment from the previous record. To read the full article click HERE.

March 12, 2013 
Have questions about when to contact TTBD or what we can offer? Join us for a brown bag presentation and Q&A on "TTBD: An Overview" on Wednesday, April 3, 2013 from 12:00-1:00pm in the Marquam Room. Click here for more details.

January 16, 2013 
Read more about the Technology Transfer and Business Development's record year in 2012 on page 5 of the January issue of the Portland Physician Scribe.

December 6, 2012 
OHSU enjoys a record 2011-2012 year in Technology Transfer and Business Development. Read the full story in OHSU News & Events.

November 27, 2012 
OHSU's Technology Transfer and Business Development office revealed this week it has reached all-time highs in terms of patents, research agreements and research funds collected from private companies.  Read more in the recent article from the Portland Business Journal (subscription required – summary available here).

October 30, 2012
2012 Technology Innovation Awardees Each year the office of Technology Transfer & Business Development honors OHSU students, faculty, and staff for their dedication to innovation and entrepreneurship at OHSU. During fiscal year 2012, the TTBD office completed 81 industry sponsored research agreements, totaling over $12.8 million in awards. Other key measures of OHSU's progress in moving discoveries toward commercialization included 117 invention disclosures, involving 209 OHSU inventors, with over 50% being first time OHSU inventors. For a full list of Technology Innovation Award recipients, view the 2012 Technology Innovation Awards program.

November 1, 2011
Patent Issed for OHSU Stem Cell Cloning Oregon Health & Science University's unique method of transforming a person's own skin cells into stem cells has officially been patented. The United States Patent and Trademark Office, an agency within the U.S. Department of Commerce, issued the patent earlier this year. Read More.

Aug 29, 2011 
Gentel Biosciences Announces Agreement with Oregon Health & Science University Gentel Biosciences, a provider of animal health research products, announces today an agreement with Oregon Health & Science University (OHSU) to license viral antigens for use in Gentel's Colony Surveillance Assays (CSA). The antigens were developed at the molecular virology core at OHSU's Oregon National Primate Research Center.

July 15, 2011
OHSU to Double Tech Transfer Office OHSU will roughly double the number of staffers in its technology transfer office, from 14 to 27.  Read More.

November 16, 2010          
Oregon Innovation Showcase 2010 Thank you to all attendees - Online Program Available The 2010 Innovation Showcase: The Design and Development of Medical Devices featured presentations from Oregon's four premier research universities and local medical device companies.Over 200 individuals from local bioscience companies, academic institutions, and the business community enjoyed an afternoon of science and networking. Thank you to all who attended.

November 4, 2010
5.4 Million Headed to Oregon Biomedical Startups Biomedical companies in Oregon secured $5.4 million from the new Therapeutic Discovery Project Program, including four OHSU Startup Companies. Lawmakers designed the program to provide tax credits and grants to small firms "that show significant potential to produce new therapies, address unmet medical needs, reduce the long-term growth of health care costs, or advance the goal of curing cancer within the next 30 years," according to the Department of Health and Human Services, which runs the program. Read More.

October 13, 2010       
OHSU Innovation and Technology Transfer Activities Up in a Down Year Despite the challenging economic climate, the OHSU technology transfer metrics demonstrate continued progress. This October, during its annual Technology Innovation Awards ceremony, Oregon Health & Science University will honor more than 100 OHSU researchers who have had a discovery licensed, a patent issued, or an invention that led to the creation of a startup company during fiscal year 2010. Read More

March 16, 2010           
DeltaPoint, Inc. named as Overall Winner at Angel Oregon 2010 DeltaPoint, Inc., a Portland-based company commercializing diagnostic software developed at OHSU's Advanced Imaging Research Center (AIRC) named overall winner at OEN's Angel Oregon 2010. Read More

March 5, 2010           
OHSU Research Produces Two Angel Oregon Finalists Two companies based on OHSU research - DeltaPoint, Inc. and Gamma Therapeutics - have been selected as finalists at OEN's Angel Oregon 2010. Read More

March 5, 2010          
OHSU Virologist Mark Slifka, Ph.D. featured as Pioneer in Scientific Community In Discovery Spotlight, Davis Wright Tremaine introduces you to pioneers in the scientific community whose work is changing our world. Read More

February 27, 2009           
Bioscience Innovation Program Awards Three Investigators The OHSU Bioscience Innovation Program (BSIP) announced awards to three investigators in 2009. The BSIP awards fill a critical gap in the funding of technologies that do not qualify for traditional federal funding, yet are deemed too early for corporate partnership... Read More Neurology Researchers Recognized at OHSU Innovation Awards